[American judge preserves confidentiality in the peer review process].
Pharmaceutical concern Pfizer subpoenaed various medical journals, including JAMA and Annals of Internal Medicine, to hand over confidential documents relating to studies on its cyclo-oxygenase-2 inhibitors celecoxib and valdecoxib. Pfizer wanted this information to help defend 3000 product liability lawsuits over alleged side effects of the 2 drugs. However, a federal judge in Chicago rejected the company's bid, thereby preserving the confidentiality of the peer review process. It is unlikely that subpoenas like this will take place in the Netherlands.